December 2007: The Pharmaceutical Sciences Division welcomes new Assistant Professors Lara Collier and Paul Marker to its Drug Action Core. Dr. Collier's research focuses on forward genetic approaches to identify genes involved in cancer initiation, progression and therapy resistance. She was most recently a postdoctoral fellow at the University of Minnesota-Twin Cities, performing research in mouse cancer and developmental genetics. She earned her PhD in cancer biology at Stanford University's School of Medicine.
Dr. Paul Marker also comes to Wisconsin from the University of Minnesota, where he has served as an assistant professor in the Department of Genetics, Cell Biology & Development since 2002. Paul earned his PhD at Stanford and was a postdoctoral fellow at the University of California, San Francisco. Marker concentrates on the molecular control of growth and morphogenesis in the prostate during development and during the progression of cancer. His areas of research interest include investigating the roles of cell-cell signaling pathways and the use of mouse genetics to discover novel prostatic oncogenes and tumor suppressors.